Investing 102

[GregWeld]

Someone was looking for drug/pharmaceutical stocks the other day...

I read Seeking Alpha "regularly" and they have a "stocks going ex-dividend"
posting... which lists several stocks that will go ex dividend shortly (within days) and I just happened to notice AstraZeneca (AZN) is going EX and has a pretty good dividend. This is a "name" that I know but rarely think about... but may be worth including in your comparison against the Bristol Meyers - etc.

Here's what the post looks like in Seeking Alpha:

AstraZeneca (AZN) has a market capitalization of $60.50 billion. The company employs 61,100 people, generates revenues of $33,591.00 million and has a net income of $10,016.00 million. The firm's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $15,345.00 million. Because of these figures, the EBITDA margin is 45.68% (operating margin 38.09% and the net profit margin finally 29.82%).

Twelve trailing months earnings per share reached a value of $7.29. Last fiscal year, the company paid $2.80 in the form of dividends to shareholders. The ex-dividend date is on February 15, 2012.

Here are the price ratios of the company: The P/E ratio is 6.47, Price/Sales 1.80 and Price/Book ratio 2.62. Dividend Yield: 5.94%. The beta ratio is 0.61.


This is another one --- WHICH I HAPPEN TO OWN.... it's a "ripper" price wise and has a good dividend...


Terra Nitrogen (TNH) has a market capitalization of $3.89 billion. The company generates revenues of $564.60 million and has a net income of $201.60 million. The firm's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $219.00 million. Because of these figures, the EBITDA margin is 38.79% (operating margin 35.76% and the net profit margin finally 35.71%).

Twelve trailing months earnings per share reached a value of $14.08. Last fiscal year, the company paid $5.01 in the form of dividends to shareholders. The ex-dividend date is on February 16, 2012.

Here are the price ratios of the company: The P/E ratio is 14.79, Price/Sales 6.82 and Price/Book ratio 18.61. Dividend Yield: 6.68%. The beta ratio is 0.74.